Orthopedics This Week

Is Urge to Merge About to Take Over Spine?

07.11.2016 - By RRY Publications, LLCPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

When Zimmer Biomet announced that it intended to buy LDR for $1 billion, investors immediately turned their attention to NuVasive, Globus and other fast growing, independent spine companies. Is Zimmer’s bid a sign that spine may start consolidating? Wall Street thinks so. But Wall Street would. What’s the real story?

More episodes from Orthopedics This Week